During CRC liver metastasis, upregulated PKLR (liver and kidney pyruvate kinase) can noncanonically destroy PKM2 enzyme activity and deregulate glycolytic metabolism to drive the malignant progression [44]. This evidence concerns the gene PKM and colorectal carcinoma.